ALZAMEND NEURO, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
ALZAMEND NEURO, INC. (ALZN) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $10.75 thousand as of 2025-01-31, per its 10-Q filed 2025-03-10.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2025-07-22
- 2025-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $10.75K.
- 2024-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $15.10K.
- 2024-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $35.10K.
- 2024-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $70.50K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-01-31 | $10.75K 10-Q · filed 2025-03-10 |
| 2024-10-31 | $15.10K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $35.10K 10-Q · filed 2024-09-11 |
| 2024-04-30 | $70.50K 10-K · filed 2025-07-22 |
| 2024-01-31 | $85.40K 10-Q · filed 2024-03-25 |
| 2023-10-31 | $174.50K 10-Q · filed 2023-12-15 |
| 2023-07-31 | $678.90K 10-Q · filed 2023-09-13 |
| 2023-04-30 | $819.90K 10-K · filed 2024-07-30 |
| 2023-01-31 | $1.33M 10-Q · filed 2023-03-15 |
| 2022-10-31 | $1.78M 10-Q · filed 2022-12-12 |
| 2022-07-31 | $1.78M 10-Q · filed 2022-09-13 |
| 2022-04-30 | $2.22M 10-K · filed 2023-07-27 |
| 2022-01-31 | $13.12M 10-Q · filed 2022-03-15 |
| 2021-10-31 | $23.46M 10-Q · filed 2021-12-13 |
| 2021-07-31 | $72.65M 10-Q · filed 2021-09-13 |
| 2021-04-30 | $35.16M 10-K · filed 2022-07-19 |
| 2020-04-30 | $15.61M 10-K · filed 2022-07-19 |
| 2019-04-30 | $15.35M 10-K · filed 2021-07-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B |